Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind, Multicenter, Phase III Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban Therapy for Women in Spontaneous Preterm Labor

NCT02292771 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02292771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02292771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind, Multicenter, Phase III Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban Therapy for Women in Spontaneous Preterm Labor
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Terminated
Start date
March 16, 2015
Completion date
August 25, 2017
Enrollment
97 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

obstetric labour, premature